Daniele Santini | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: the EverExt study	SCIENTIFIC REPORTS	2017
Immunotherapy for colorectal cancer: where are we heading?	EXPERT OPINION ON BIOLOGICAL THERAPY	2017
Efficacy and safety of T-DM1 in the 'common-practice' of HER2+ advanced breast cancer setting: a multicenter study	ONCOTARGET	2017
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: A multicenter retrospective analysis	EUROPEAN JOURNAL OF CANCER	2017
Prognostic value of systemic inflammatory biomarkers in patients with mCRPC treated with abiraterone in pre-docetaxel setting	ANNALS OF ONCOLOGY	2017
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world	GASTRIC CANCER	2017
Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough	FUTURE ONCOLOGY	2017
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation	BRITISH JOURNAL OF CANCER	2017
Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain	EUROPEAN JOURNAL OF CANCER	2017
Immunotherapeutic approaches for hepatocellular carcinoma	ONCOTARGET	2017
TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group	BMC CANCER	2017
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? (vol 23, pg 2313, 2012)	ANNALS OF ONCOLOGY	2017
Developing drugs in cancer-related bone pain	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY	2017
Olaratumab: PDGFR-alpha inhibition as a novel tool in the treatment of advanced soft tissue sarcomas	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY	2017
Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale	EUROPEAN JOURNAL OF CANCER	2017
Change from lung adenocarcinoma to small cell lung cancer as a mechanism of resistance to afatinib	ONCOTARGET	2017
Antiangiogenic agents after first line and sorafenib plus chemoembolization: a systematic review	ONCOTARGET	2017
The ‘Charter of Rights for Family Caregivers’. The role and importance of the caregiver: an Italian proposal	ESMO OPEN	2017
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis	ONCOTARGET	2017
HER2 status in gastric cancer: Comparison between primary and distant metastatic disease	PATHOLOGY ONCOLOGY RESEARCH	2017